Daniel Arias analyst STIFEL

Currently out of the existing stock ratings of Daniel Arias, 170 are a BUY (64.89%), 92 are a HOLD (35.11%).

Daniel Arias

Work Performance Price Targets & Ratings Chart

Analyst Daniel Arias, currently employed at STIFEL, carries an average stock price target met ratio of 64.11% that have a potential upside of 22.69% achieved within 185 days.

Daniel Arias’s has documented 518 price targets and ratings displayed on 31 stocks. The coverage is on Healthcare, Basic Materials, Technology sectors.

Most recent stock forecast was given on DHR, Danaher at 22-Jul-2026.

Wall Street Analyst Daniel Arias

Analyst best performing recommendations are on TEM (TEMPUS AI, COMMON STOCK).
The best stock recommendation documented was for TEM (TEMPUS AI, COMMON STOCK) at 8/11/2025. The price target of $65 was fulfilled within 1 day with a profit of $4.18 (6.87%) receiving and performance score of 68.73.

Average potential price target upside

A Agilent Technologies AVTR Avantor BLI Berkeley Lights  BRKR Bruker EXAS EXACT Sciences GH Guardant Health ILMN Illumina LMNX Luminex MASS 908 Devices MRVI Maravai Lifesciences Holdings  RGEN Repligen RNLX Renalytix AI TECH Bio-Techne Corp TMO Thermo Fisher Scientific TXG 10X Genomics WAT Waters ABSI Absci Corp CDXS Codexis DHR Danaher PKI PerkinElmer MTD Mettler-Toledo International NSTG NanoString Technologies QGEN Qiagen NV SLGC Somalogic TX Ternium SA ADR MXCT MaxCyte TEM Tempus AI, Common Stock AA Alcoa Corp BL Blackline PK Park Hotels & Resorts RVTY Revvity

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 09-Jul-2026

$135

$-3.57 (-2.58%)

$180

23 days ago
(09-Jul-2026)

8/10 (80%)

$1.41 (1.06%)

237

Buy Since 06-Apr-2026

$148

$9.43 (6.81%)

$140

26 days ago
(06-Jul-2026)

7/10 (70%)

$17.4 (13.32%)

27

Buy Since 26-Feb-2026

$150

$13.99 (10.29%)

$145

1 months 7 days ago
(24-Jun-2026)

16/22 (72.73%)

$18.37 (13.96%)

122

Buy Since 02-Jun-2026

$155

$18.99 (13.96%)

$145

1 months 29 days ago
(02-Jun-2026)

9/13 (69.23%)

$19.95 (14.77%)

164

Buy Since 24-May-2023

$155

$18.99 (13.96%)

$165

2 months 3 days ago
(28-May-2026)

15/20 (75%)

$19.62 (14.49%)

249

Show more analysts

Please expand the browser size to see the chart

Which stock is Daniel Arias is most bullish on?

Potential upside of $35.08 has been obtained for GH (GUARDANT HEALTH)

Which stock is Daniel Arias is most reserved on?

Potential downside of -$21.27 has been obtained for TXG (10X GENOMICS)

What Year was the first public recommendation made by Daniel Arias?

On 2008

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?